TSRI scientists receive $15 million to study viral outbreak survivors. With a new $15 million grant, scientists at The Scripps Research Institute (TSRI) are gearing up for an in-depth study of survivors of viral outbreaks. The grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases will support the efforts of the TSRI-led Center for Viral…
In a recent study published in Cell together with colleagues from UMass Worcester and the Broad, we show how a single mutation that occurred during the 2013-2016 Ebola virus disease epidemic in West Africa increased the ability of the virus to infect human cells. The mutation occurred in the Ebola virus glycoprotein and is located in the receptor binding domain of…
The 2013-2016 Ebola epidemic in West Africa was of unprecedented size and devastation, but also stands a landmark for infectious disease genomics. By sequencing virus genomes directly from patient samples, scientists are now able to investigate how viruses evolve, transmit between individuals, and spread across country borders during outbreaks, directly informing infection control.
In a technical comment in Science, we show how a study published in 2015 by Hoenen, Feldmann, and others was based on faulty analyzes and a misunderstanding of the findings. The original article by the authors, as well as a later published erratum, failed to account for significant data analysis errors performed by Hoenen and colleagues.
Infectious disease outbreaks continue to pose challenges to global health and security, prompting reactive countermeasures. Recently, severe outbreaks of Ebola and Zika virus were designated by the World Health Organization as “Public Health Emergencies of International Concern.” Other emerging viral pathogens have warranted similar attention, including virus outbreaks from Lassa, Chikungunya, avian influenza, Nipah, SARS, and MERS.
The leading Danish newspaper Politiken had a feature on our work in the September 20th 2015 Sunday section. The article discusses our past and ongoing work with Lassa and Ebola. The full feature describes how we have investigated both Lassa and Ebola virus evolution based on our most recent papers in Cell and Science.
In a large multi-disciplinary collaboration between partners in Sierra Leone, Nigeria, USA, and Europe, we have published our first study on Lassa virus evolution. The paper – which appears on the front page of the August issue of Cell – is the result of seven years of work on Lassa fever across West Africa.
Erika Check Hayden – who is a frequent contributor to Nature News and others – just published an article in Wired Magazine describing some of the work we do as part of the Viral Hemorrhagic Fever Consortium. The article is focused on our work with Ebola survivors and outlines our research aimed at find new and better treatments for Ebola.